Researching Ebola in Africa: The Partnership for Research on Ebola Virus in Liberia (PREVAIL)
Item
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Title
Researching Ebola in Africa: The Partnership for Research on Ebola Virus in Liberia (PREVAIL)
Subject
Description
The 2014-2016 Ebola outbreak in West Africa was the largest in history, with nearly 28,700 cases and more than 11,300 deaths. As local and international healthcare workers responded to the outbreak, the U.S. National Institute of Allergy and Infectious Diseases (NIAID) and the Ministry of Health in Liberia—one of the hardest-hit countries—established PREVAIL, or the Partnership for Research on Ebola Virus in Liberia. Specifically, the partnership was quickly formed in 2014 in response to a request from the Liberian Minister of Health to the U.S. Secretary of Health and Human Services. Since then PREVAIL has conducted biomedical research according to rigorous international standards to advance Ebola science and to improve the health of people in Liberia and around the world. Collaborative teams of Liberian and NIAID investigators have launched multiple clinical studies to evaluate candidate Ebola treatments and vaccines, and to better understand the long-term health effects of Ebola in those who survive the disease. The PREVAIL clinical research agenda is also expanding beyond Ebola research to address additional health needs of the Liberian people. (NIH)
Creator
Date
2019-01-04
Accessibility
Free online
Was this resource helpful?